These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

298 related articles for article (PubMed ID: 33930041)

  • 21. Subretinal recombinant tissue plasminogen activator injection and pneumatic displacement of thick submacular hemorrhage in Age-Related macular degeneration.
    Olivier S; Chow DR; Packo KH; MacCumber MW; Awh CC
    Ophthalmology; 2004 Jun; 111(6):1201-8. PubMed ID: 15177972
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Treatment of hematomas in age related macular degeneration by vitrectomy and subretinal injection of r-tPA: Preliminary results.
    Boiché M; Angioi-Duprez K; Conart JB; Berrod JP
    J Fr Ophtalmol; 2019 Nov; 42(9):e391-e397. PubMed ID: 31471124
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Intravitreal Recombinant Tissue Plasminogen Activator and Sulphur Hexafluoride Gas for Submacular Haemorrhage Displacement in Age-Related Macular Degeneration: Looking behind the Blood.
    Maggio E; Peroglio Deiro A; Mete M; Sartore M; Polito A; Prigione G; Guerriero M; Pertile G
    Ophthalmologica; 2020; 243(3):224-235. PubMed ID: 31905361
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Vitrectomy, subretinal Tissue plasminogen activator and Intravitreal Gas for submacular haemorrhage secondary to Exudative Age-Related macular degeneration (TIGER): study protocol for a phase 3, pan-European, two-group, non-commercial, active-control, observer-masked, superiority, randomised controlled surgical trial.
    Jackson TL; Bunce C; Desai R; Hillenkamp J; Lee CN; Lois N; Peto T; Reeves BC; Steel DH; Edwards RT; van Meurs JC; Wafa H; Wang Y
    Trials; 2022 Jan; 23(1):99. PubMed ID: 35101110
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Efficacy and safety of recombinant tissue plasminogen activator and gas versus bevacizumab and gas for subretinal haemorrhage.
    Mayer WJ; Hakim I; Haritoglou C; Gandorfer A; Ulbig M; Kampik A; Wolf A
    Acta Ophthalmol; 2013 May; 91(3):274-8. PubMed ID: 21952010
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Management of thick submacular hemorrhage with subretinal tissue plasminogen activator and pneumatic displacement for age-related macular degeneration.
    Chang W; Garg SJ; Maturi R; Hsu J; Sivalingam A; Gupta SA; Regillo CD; Ho AC
    Am J Ophthalmol; 2014 Jun; 157(6):1250-7. PubMed ID: 24531021
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Successful displacement of a traumatic submacular hemorrhage in a 13-year-old boy treated by vitrectomy, subretinal injection of tissue plasminogen activator and intravitreal air tamponade: a case report.
    Doi S; Kimura S; Morizane Y; Shiode Y; Hosokawa M; Hirano M; Hosogi M; Fujiwara A; Miyamoto K; Shiraga F
    BMC Ophthalmol; 2015 Aug; 15():94. PubMed ID: 26250101
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Literature review of recombinant tissue plasminogen activator used for recent-onset submacular hemorrhage displacement in age-related macular degeneration.
    van Zeeburg EJ; van Meurs JC
    Ophthalmologica; 2013; 229(1):1-14. PubMed ID: 23075629
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Intravitreal bevacizumab in AMD complicated by submacular hemorrhage].
    Bouraoui R; Bouladi M; Kort F; Limaiem R; Mghaieth F; El Matri L
    J Fr Ophtalmol; 2016 Mar; 39(3):248-54. PubMed ID: 26995076
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Surgical management of submacular hemorrhage due to n-AMD: a comparison of three surgical methods.
    Grohmann C; Dimopoulos S; Bartz-Schmidt KU; Schindler P; Katz T; Spitzer MS; Skevas C
    Int J Retina Vitreous; 2020; 6():27. PubMed ID: 32637155
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Treatment of submacular hemorrhage with tissue plasminogen activator and pneumatic displacement in age-related macular degeneration.
    Sniatecki JJ; Ho-Yen G; Clarke B; Barbara R; Lash S; Papathomas T; Antonakis S; Gupta B
    Eur J Ophthalmol; 2021 Mar; 31(2):643-648. PubMed ID: 31813290
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Comparison between different techniques for treatment of submacular haemorrhage due to Age-Related Macular Degeneration.
    Kishikova L; Saad AAA; Vaideanu-Collins D; Isac M; Hamada D; El-Haig WM
    Eur J Ophthalmol; 2021 Sep; 31(5):2621-2624. PubMed ID: 32993349
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Modified Approach in Management of Submacular Hemorrhage Secondary to Wet Age-Related Macular Degeneration.
    Kumar A; Roy S; Bansal M; Tinwala S; Aron N; Temkar S; Pujari A
    Asia Pac J Ophthalmol (Phila); 2016; 5(2):143-6. PubMed ID: 26302314
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Outcomes of vitrectomy combined with subretinal tissue plasminogen activator injection for submacular hemorrhage associated with polypoidal choroidal vasculopathy.
    Kimura S; Morizane Y; Hosokawa MM; Shiode Y; Doi S; Hosogi M; Fujiwara A; Okanouchi T; Inoue Y; Shiraga F
    Jpn J Ophthalmol; 2019 Sep; 63(5):382-388. PubMed ID: 31243593
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Efficacy of Vitrectomy Combined with Subretinal Recombinant Tissue Plasminogen Activator for Subretinal versus Subpigment Epithelial versus Combined Hemorrhages.
    Waizel M; Todorova MG; Kazerounian S; Rickmann A; Blanke BR; Szurman P
    Ophthalmologica; 2016; 236(3):123-132. PubMed ID: 27631507
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Subretinal Coapplication of Tissue Plasminogen Activator and Bevacizumab with Concurrent Pneumatic Displacement for Submacular Hemorrhages Secondary to Neovascular Age-Related Macular Degeneration.
    Avcı R; Mavi Yıldız A; Çınar E; Yılmaz S; Küçükerdönmez C; Akalp FD; Avcı E
    Turk J Ophthalmol; 2021 Feb; 51(1):38-44. PubMed ID: 33631914
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Naïve subretinal haemorrhage due to neovascular age-related macular degeneration. pneumatic displacement, subretinal air, and tissue plasminogen activator: subretinal vs intravitreal aflibercept-the native study.
    Iglicki M; Khoury M; Melamud JI; Donato L; Barak A; Quispe DJ; Zur D; Loewenstein A
    Eye (Lond); 2023 Jun; 37(8):1659-1664. PubMed ID: 36038720
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Intravitreal Expansile Gas and Bevacizumab Injection for Submacular Hemorrhage Due to Neovascular Age-related Macular Degeneration.
    Nourinia R; Bonyadi MH; Ahmadieh H
    J Ophthalmic Vis Res; 2010 Jul; 5(3):168-74. PubMed ID: 22737352
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Pars plana vitrectomy, subretinal injection of tissue plasminogen activator, and fluid-gas exchange for displacement of thick submacular hemorrhage in age-related macular degeneration.
    Haupert CL; McCuen BW; Jaffe GJ; Steuer ER; Cox TA; Toth CA; Fekrat S; Postel EA
    Am J Ophthalmol; 2001 Feb; 131(2):208-15. PubMed ID: 11228297
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Intravitreal tissue plasminogen activator and pneumatic displacement of submacular hemorrhage.
    Kung YH; Wu TT; Hong MC; Sheu SJ
    J Ocul Pharmacol Ther; 2010 Oct; 26(5):469-74. PubMed ID: 20925578
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.